In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Scientists might be able to quickly predict how ovarian cancer patients are likely to respond to chemotherapy treatment using a simple blood test.
Cancer clinician Professor Stan Kaye has been awarded the Lifetime Achievement in Cancer Research Prize by Cancer Research UK today.
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.
Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.
A drug already approved for leukaemia patients could also be used to treat a specific type of ovarian cancer.